DiscoverBioVenture VoiCes with Chris GarabedianEpisode 22: Adjuvant Capital's Glenn Rockman
Episode 22: Adjuvant Capital's Glenn Rockman

Episode 22: Adjuvant Capital's Glenn Rockman

Update: 2025-06-30
Share

Description

Glenn Rockman describes the introduction to impact investing he gained from working for J.P. Morgan and along with the Gates Foundation on the Global Health Investment Fund, and how the idea of investing for public good ultimately sparked Adjuvant Capital in 2019. Armed with a $300M+ fund that was raised from numerous foundations and for-profit funds in 2021, Adjuvant has been investing in public health technologies, post proof of concept, to help accelerate their development and ultimately make them more accessible to those around the world who need them.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 22: Adjuvant Capital's Glenn Rockman

Episode 22: Adjuvant Capital's Glenn Rockman

BiotechTV